Biocon
Lance Giordano is an experienced professional in the pharmaceutical and healthcare industries, currently serving as the Head of National Accounts at Biocon since August 2018. Prior roles include Vice President of Sales & Marketing at Micro Labs Limited and Genus Lifesciences Inc. from June 2016 to August 2018 and June 2013 to March 2016, respectively. Lance held various positions at Sanofi, Cadista Pharmaceuticals, Endo Pharmaceuticals, IQVIA, Sandoz, and Pfizer, ranging from Director to Product Manager. Educational qualifications include an MBA in Marketing from Villanova University and a Bachelor of Science in Business Administration from La Salle University.
This person is not in any teams
This person is not in any offices
Biocon
21 followers
Biocon Limited is a biopharmaceutical company. The Company focuses to reduce therapy costs of chronic diseases like autoimmune, diabetes, and cancer. Through its products and research services it is enabling access to affordable healthcare for patients, partners and healthcare systems across the globe. The Company has developed and taken a range of Novel Biologics, Biosimilars, differentiated Small Molecules and affordable Recombinant Human Insulin and Analogs from Lab to Market. The Company's brands include INSUGEN (rh-insulin), BASALOG (Glargine), CANMAb (Trastuzumab), BIOMAb-EGFR (Nimotuzumab) and ALZUMAb (Itolizumab), an anti-CD6 monoclonal antibody. It has a pipeline of Biosimilars and Novel Biologics at various stages of development, including Insulin Tregopil, an oral insulin analog.